NPR reports:
The House of Representatives voted to approve legislation that would limit cost-sharing for insulin under private health insurance and Medicare. The vote was 232-193, with 12 Republican members joining their Democratic colleagues to pass the measure.
The Affordable Insulin Now Act would cap insulin prices at either $35 a month or 25% of an insurance plan’s negotiated price — whichever is lower. The legislation aims to take effect in 2023 but its fate in the Senate remains unclear.
Read the full article.
Tonight @HouseDemocrats voted to cap insulin costs at $35 a month.
Meanwhile Kevin McCarthy’s Republicans are bragging about having orgies and doing cocaine.
That’s the difference between being for the people or for the powder. https://t.co/py54zQrgjs
— Rep. Eric Swalwell (@RepSwalwell) April 1, 2022
Democrats and a few House Republicans passed a bill to cap out-of-pocket costs on insulin at $35. Now, on to the Senate! https://t.co/SZRqWahTGK
— CAP Action (@CAPAction) April 1, 2022
12 House Republicans voted Yes for $35 insulin cap bill:
Bacon (NE)
Fitzpatrick (PA)
Harris (MD)
Herrera Beutler (WA)
Hudson (NC)
Katko (NY)
Malliotakis (NY)
Meuser (PA)
Miller-Meeks (IA)
Posey (FL)
Smith (NJ)
Upton (MI)https://t.co/pXosOb4ri3— Craig Caplan (@CraigCaplan) March 31, 2022